Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Thromb Haemost. 2011 Oct;9(10):2087–2096. doi: 10.1111/j.1538-7836.2011.04454.x

Fig. 1.

Fig. 1

Characterization of the anti-human TF antibodies used in the study. (A) Reactivity of the four antibodies with recombinant asTF and LZ-TF: the indicated amounts of protein are in ng. (B) Specificity of the isoform-specific anti-TF antibodies: the indicated amounts of total protein (lysates of cervical adenocarcinoma) are in μg; blots we stripped and re-probed with anti-G3PDH antibody.